EPIC | APH |
Sector | Pharma and Biotech |
ISIN | GB0031030819 |
Market Sector | AIM |
Market Segment | AMSM |
Main Indices | FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100 |
Country of register | Great Britain |
Currency | British Pound |
Market Cap | £230.01m |
NMS | 15,000 |
Shares in issue | 540.57m |
Date Listed | 23-Dec-2003 |
Currency | UK Pounds |
Share Price | 42.55p |
Change Today | -0.95p |
% Change | -2.18 % |
52 Week High | 44.80 |
52 Week Low | 29.35 |
Volume | 1,560,544 |
Shares Issued | 540.57m |
Market Cap | £230.01m |
Beta | 0.01 |
RiskGrade | 119 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 0 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 22-Jun-23 | 22-Dec-22 |
Paid | 18-Jul-23 | 19-Jan-23 |
Amount | 1.18p | 0.59p |
Time | Volume / Share Price |
16:24 | 5,900 @ 42.55p |
16:24 | 6,120 @ 42.60p |
16:24 | 553 @ 42.60p |
16:24 | 52,356 @ 42.37p |
16:15 | 472 @ 43.00p |
CFO | Andrew Franklin |
Chair | Camillo Pane |
CEO | Nick Sedgwick |
You are here: research